Journal of Pharmacological and Toxicological Methods

Papers
(The median citation count of Journal of Pharmacological and Toxicological Methods is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Use of automated patch clamp in cardiac safety assessment: past, present and future perspectives20
Chicken embryo as animal model to study drug distribution to the developing brain17
Improving the in Vivo QTc assay: The value of implementing best practices to support an integrated nonclinical-clinical QTc risk assessment and TQT substitute16
Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14/S7B Q&As14
Caenorhabditis elegans as a possible model to screen anti-Alzheimer's therapeutics14
Biochemical characterization of high fat diet fed and low dose streptozotocin induced diabetic Wistar rat model13
Determination of the alcohol biomarker phosphatidylethanol 16:0/18:1 and 33 compounds from eight different drug classes in whole blood by LC-MS/MS12
Characterization of iCell cardiomyocytes using single-cell RNA-sequencing methods12
Intratracheal administration of solutions in mice; development and validation of an optimized method with improved efficacy, reproducibility and accuracy12
Comparison of RPMI 2650 cell layers and excised sheep nasal epithelial tissues in terms of nasal drug delivery and immunocytochemistry properties12
The in vivo QTc core assay: An evaluation of QTc variability, detection sensitivity and implications for the improvement of conscious dog and non-human primate telemetry studies12
A novel murine model of pulmonary fibrosis: the role of platelets in chronic changes induced by bleomycin10
High-content analysis and Kinetic Image Cytometry identify toxicity and epigenetic effects of HIV antiretrovirals on human iPSC-neurons and primary neural precursor cells10
Improving corrected QT; Why individual correction is not enough9
Efficient and modified 2-NBDG assay to measure glucose uptake in cultured myotubes9
Experimental model of congestive heart failure induced by transverse aortic constriction in BALB/c mice9
Core battery safety pharmacology testing – An assessment of its utility in early drug development9
Development of an easy and rapid analytical method for the extraction and preconcentration of chloroquine phosphate from human biofluids prior to GC–MS analysis9
Characterization of a commercially available line of iPSC hepatocytes as models of hepatocyte function and toxicity for regulatory purposes9
Analysis of secondary pharmacology assays received by the US Food and Drug Administration8
A tiered approach to population-based in vitro testing for cardiotoxicity: Balancing estimates of potency and variability8
Simultaneous determination of barbiturates, phenytoin and topiramate in hair by LC-MS/MS and application to real samples8
Comparison of validity of standard nonclinical group size selection versus standard clinical group sizes for nonhuman primate QTc prolongation evaluation8
Use of automated patch clamp in cardiac safety assessment: Past, present & future perspectives8
Validation of steroid sulfates deconjugation for metabolic studies. Application to human urine samples7
Acute cell stress screen with supervised machine learning predicts cytotoxicity of excipients7
Use of the ZDF rat to model dietary fat induced hypercoagulability is limited by progressive and fatal nephropathy7
Cytochrome P450 3A4 (CYP3A4) protein quantification using capillary western blot technology and total protein normalization7
Use of computed tomography to assess subcutaneous drug dispersion with recombinant human hyaluronidase PH20 in a swine model7
One step derivatization and dispersive liquid-liquid microextraction of hydroxychloroquine sulfate for its sensitive and accurate determination using GC–MS7
Aggregation and analysis of secondary pharmacology data from investigational new drug submissions at the US Food and Drug Administration6
Combination of quadrupole isotope dilution mass spectrometry with simultaneous derivatization and spray assisted droplet formation-liquid phase microextraction for the determination of methamphetamine6
Brain-derived neurotrophic factor for high-throughput evaluation of selective Sigma-1 receptor ligands6
hERG block potencies for 5 positive control drugs obtained per ICH E14/S7B Q&As best practices: Impact of recording temperature and drug loss6
“Appraisal of state-of-the-art” The 2021 Distinguished Service Award of the Safety Pharmacology Society: Reflecting on the past to tackle challenges ahead6
The use of hypercapnic conditions to assess opioid-induced respiratory depression in rats6
Seizure-induced Torsades de pointes:In a canine drug-induced long-QT1 model6
Reliable identification of cardiac conduction abnormalities in drug discovery using automated patch clamp II: Best practices for Nav1.5 peak current in a high throughput screening environment6
Non invasive jacketed telemetry in socially-housed rats for a combined assessment of respiratory system, electrocardiogram and activity using the DECRO system5
Novel in vivo and ex vivo hybrid in vivo imaging system (IVIS) imaging offers a convenient and precise way to measure the glomerular filtration rate in conscious mice5
A stable cell line inducibly expressing hERG1a/1b heteromeric channels5
Establishment of a new nonalcoholic steatohepatitis model; Ovariectomy exacerbates nonalcoholic steatohepatitis-like pathology in diabetic rats5
Prediction of GABA receptor antagonist-induced convulsion in cynomolgus monkeys by combining machine learning and heart rate variability analysis5
Novel microvascular endothelial model utilizing a collagen vitrigel membrane and its advantages for predicting histamine-induced microvascular hyperpermeability5
Development of a method to determine cytochrome P450 1A2, 2C9, 2D6 and 3A4 activity sheep hepatic microsomes5
Genomics Integrated Systems Transgenesis (GENISYST) for gain-of-function disease modelling in Göttingen Minipigs5
Differentiating multichannel block on the guinea pig ECG: Use of Tpeak-Tend and J-Tpeak5
Optimization of a histamine-induced allergic conjunctivitis model in Guinea pigs4
Pressure-based estimation of right ventricular ejection fraction: Validation as a clinically relevant target for drug development in a rodent model of pulmonary hypertension4
LC-MS/MS method for rapid and accurate detection of caffeine in a suspected overdose case4
Implantation of telemetric blood pressure transmitters in Göttingen Minipigs: Validation of 24-h systemic blood pressure and heart rate monitoring and influence of anaesthesia4
Optimization of a method to detect levothyroxine and related compounds in serum and urine by liquid chromatography coupled to triple quadrupole mass spectrometry4
The 2-year rodent bioassay in drug and chemical carcinogenicity testing: Performance, utility, and configuration for cancer hazard identification4
Sensitive and rapid method for the quantitation of amoxicillin in minipig plasma and milk by LC-MS/MS: A contribution from the IMI ConcePTION project4
Fluorescent opioid receptor ligands as tools to study opioid receptor function4
Importance of beating rate control for the analysis of drug effects on contractility in human induced pluripotent stem cell-derived cardiomyocytes4
Optimization of psoriasis mouse models4
Safety pharmacology 2023 and implementation of the ICH E14/S7B Q&A guidance document4
In vitro model using cytokine cocktail to evaluate apoptosis in Min6 pancreatic beta cells4
On the perspective of an aging population and its potential impact on drug attrition and pre-clinical cardiovascular safety assessment4
High throughput measurement of hERG drug block kinetics using the CiPA dynamic protocol4
Contractility assessment of human iPSC-derived cardiomyocytes by using a motion vector system and measuring cell impedance4
An integrative pharmacokinetic-cardiovascular physiology modelling approach based on in vivo dog studies including five reference compounds3
Strategies to encourage the adoption of social housing during cardiovascular telemetry recordings in non-rodents3
Development and validation of a LC-MS/MS method for simultaneous quantification of Ivabradine and Metoprolol in rat plasma3
Amphetamine, methamphetamine, and MDMA in hair samples from a rehabilitation facility: Validation and applicability of HF-LPME-GC-MS3
Schiefer counter: An alternative method for clonogenic assay evaluation3
In-house fabrication of bipolar electrode-cannula assembly for electrical stimulation and drug delivery at the same site in rat brain3
Enhancing the functional maturity of hiPSC-derived cardiomyocytes to assess inotropic compounds3
Automated blood sampling in canine telemetry studies: Enabling enhanced assessments of cardiovascular liabilities and safety margins3
Electrocardiography and heart rate variability in Göttingen Minipigs: Impact of diurnal variation, lead placement, repeatability and streptozotocin-induced diabetes3
The impact of environmental and biological factors on the resting heart rate of dogs as assessed using 20 years of data from safety pharmacology studies3
Simultaneous quantification of thalidomide, lenalidomide and pomadomide in plasma by LC-MS/MS3
Reference intervals and method sensitivity for electrocardiology, hemodynamics, and body temperature parameters in healthy cynomolgus monkeys3
Simulated traumatic brain injury in in-vitro mouse neuronal and brain endothelial cell culture models3
Standardization and validation of novel ex-vivo method for mitochondrial bioenergetics using mitochondrial modulators3
A mouse model of allergic conjunctivitis permitting tear eosinophil quantification3
Validation of an LC–MS/MS method for quantitation of fostemsavir in plasma3
Optimization of bioanalysis of dried blood samples3
Quantitative protein profiling of phenobarbital-induced drug metabolizing enzymes in rat liver by liquid chromatography mass spectrometry using formalin-fixed paraffin-embedded samples3
Development of a bridging ELISA for detection of antibodies against ZV0203 in cynomolgus monkey serum3
Comparing the sensitivity of cross-over and parallel study designs for QTc assessment: An analysis based on a single large study of moxifloxacin in 48 nonhuman primates3
Assessment of intracellular accumulation of cadmium and thallium2
Nonclinical cardiovascular safety assessment of thioridazine: Impact of autonomic tone, body temperature, and choice of species2
A/J mice are more susceptible than C57BL/6 to acetaminophen-induced hepatotoxicity2
Alloxan as a better option than streptozotocin for studies involving painful diabetic neuropathy2
Development of binary classification models for assessment of drug-induced liver injury in humans using a large set of FDA-approved drugs2
An optimized method for intratracheal instillation in mice2
Disconnect between COX-2 selective inhibition and cardiovascular risk in preclinical models2
A new group housing approach for non-human primate metabolism studies2
Overview of the bioanalytical methods used for the determination of benzodiazepines in biological samples and their suitability for emergency toxicological analysis2
The incidence of spontaneous arrhythmias in telemetered beagle dogs, Göttingen Minipigs and Cynomolgus non-human primates: A HESI consortium retrospective analysis2
Peanut butter as an alternative dose delivery method to prevent strain-dependent orogastric gavage-induced stress in mouse teratogenicity studies2
Accurate in silico simulation of the rabbit Purkinje fiber electrophysiological assay to facilitate early pharmaceutical cardiosafety assessment: Dream or reality?2
A comparison of the performance of contemporary, historical, and cross-lab controls in QTc assessment in conscious nonhuman primates2
L-citrulline: A preclinical safety biomarker for the small intestine in rats and dogs in repeat dose toxicity studies2
l-citrulline: A preclinical safety biomarker for the small intestine in rats and dogs in repeat dose toxicity studies2
Non-uniformity in in vitro drug-induced cytotoxicity as evidenced by differences in IC50 values – implications and way forward2
QT Ratio: A simple solution to individual QT correction2
Characterization of an i.p. D-galactose-induced cataract model in rats2
Δ9-tetrahydrocannabinol: Drug discrimination abuse liability testing in female Lister Hooded rats: Trials, tribulations and triumphs2
In vitro cardiac safety evaluation for repurposed COVID-19 drugs by using human iPS cell-derived cardiomyocyte with gelatin fiber scaffold1
Do behavioral test scores represent repeatable phenotypes of female mice?1
In silico modelling of stroke volume, cardiac output and systemic vascular resistance in cardiovascular safety pharmacology studies by telemetry1
Off-target pharmacological activity at various kinases: Potential functional and pathological side effects1
An electrochemiluminescence assay for quantification of Denileukin Diftitox and its anti-drug antibodies in rat serum1
Nonclinical pharmacokinetics of E3112, a recombinant human hepatocyte growth factor, in rats and monkeys by a simple ELISA kit assay1
Characteristics of histamine H4 receptor agonist-induced allergic conjunctivitis model in Guinea pigs1
Protein malnutrition in BALB/C mice: A model mimicking clinical scenario of marasmic-kwashiorkor malnutrition1
Comparison of cell viability methods for human mesenchymal/stromal stem cells and human A549 lung carcinoma cells after freeze-thaw stress1
Study design criteria for regulatory-based drug control action: Drug discrimination1
Validation of a simple spectrophotometric method for the rapid determination of salicylates in plasma1
A simple accurate method for concentration-QTc analysis in preclinical animal models1
The rat telemetry assay and venous catheter access buttons for use in cardiovascular safety pharmacology assessments – Surgical methods, refinements and colony maintenance1
Lung physiology and controlled exposure study design1
Bayesian approach enabled objective comparison of multiple human iPSC-derived Cardiomyocytes' Proarrhythmia sensitivities.1
Chamber-specific contractile responses of atrial and ventricular hiPSC-cardiomyocytes to GPCR and ion channel targeting compounds: A microphysiological system for cardiac drug development1
An immunoblot assay for cysteine oxidation by reactive oxygen species allows detection of novel thioprotective efficacy of black tea extracts1
A rapid spectrophotometric method to identify inhibitors of human erythropoiesis1
Safety pharmacology in 2022: Taking one small step for cardiovascular safety assay development but one giant leap for regulatory drug safety assessment1
Revisiting the high-fat diet/low streptozotocin prediabetic rat model: A bioanalytical adjustment1
Comparative assessment of Ca2+ oscillations in 2- and 3-dimensional hiPSC derived and isolated cortical neuronal networks1
A highly efficient liquid chromatography–tandem mass spectrometry (LC–MS/MS) assay for etomidate and etomidate acid in urine, liver and kidney1
A generalized canine transfer function accurately reconstructs central aortic pressure waveforms to enable enhanced pulse wave analysis1
Contractility assessment using aligned human iPSC-derived cardiomyocytes1
A method for assessing and monitoring consistency of nonclinical ECG analysis1
Non-invasive method of obtaining milk from mice using carbetocin, a synthetic analogue of oxytocin1
Detecting immunotoxicity in vitro—clinically relevant studies in the COVID-19 era1
Improving the in vivo QTc assay: Nonclinical concentration-QTc modeling for risk assessment1
Supporting an integrated QTc risk assessment using the hERG margin distributions for three positive control agents derived from multiple laboratories and on multiple occasions.1
Automated blood sampling in canine telemetry studies: Enabling enhanced assessments of cardiovascular liabilities and safety margins1
Less invasive, simultaneous, and continuous measurements of locomotor activity and body temperature using the nano tag® small accelerometer device in cynomolgus monkeys1
Comparison of electrocardiogram and blood pressure recording methods in non-rodent toxicology studies: A retrospective analysis1
Mouse models for actinic keratoses1
Characterization of ascending dose canine telemetry model supports its use in E14/S7B QT integrated risk assessments1
Virtual clinical QT exposure-response studies – A translational computational approach1
Assessment of corrected JT-peak (JTpc) and Tpeak-to-Tend (TpTec) as proarrhythmia biomarkers in non-human primates: Outcome from a HESI consortium1
Novel method for determination of colistin sulfate in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its clinical applications in critically ill patients1
Development of a pharmaceutical database as an aid to the nonclinical detection of drug-induced cardiac toxicity1
Comparative study for the IMI2-NeuroDeRisk project on microelectrode arrays to derisk drug-induced seizure liability1
Maximizing insights from nonclinical safety studies in the context of rising costs and changing regulations1
Development, validation, and clinical application of a UPLC-MS/MS method for omadacycline determination in human serum1
A comparison of activity data generated from cardiovascular telemetry studies - With quantitative open field locomotor studies in Wistar Han rats1
Use of subcutaneous transponders to monitor body temperature in laboratory rats1
Optimized J to T peak and T peak to T end measurements in nonclinical species administered moxifloxacin and amiodarone1
Adaptation of closed-chest infarction porcine model to adult Pannon minipigs1
hERG agonists pose challenges to web-based machine learning methods for prediction of drug-hERG channel interaction1
Ultraviolet spectrophotometry as method to determine the concentration of β-myrcene released from chitosan in aqueous medium1
Screening of anticonvulsant activity of Xylopia aethiopica dry fruit using zebrafish0
Measuring the impact of known inotropes on rat papillary muscles via the force-clamped feedback work-loop0
A personal reflection on 23 years of the Journal of pharmacological and toxicological methods0
Diisopropylfluorophosphate (DFP) volatizes and cross-contaminates wells in a common 96-well plate format used in zebrafish larvae toxicology studies0
Understanding lymphatic drug delivery through chylomicron blockade: A retrospective and prospective analysis0
Comparison of automated analysis methods for small animal activity assessment0
Development of a medium throughput whole-cell microtiter plate Thr286 autophosphorylation assay for CaMKIIα using ELISA0
Development of simultaneous determination of dopamine 2, histamine 1, and muscarinic acetylcholine receptor occupancies by antipsychotics using liquid chromatography with tandem mass spectrometry0
Safety Pharmacology Society Annual Meeting Abstracts0
Molecular imaging of excitability difference between alkaloids/salts (nicotine, nicotinic benzoate, caffeine and arecoline hydrobromide)0
A fast optical kinetic plate reader for assessing action potentials in human-induced pluripotent stem cell cardiomyocytes0
Phenylthiourea-mediated experimental depigmentation reduces seizurogenic response of pentylenetetrazol in zebrafish larva0
Evaluation of three different 99mTc-based mock-venom agents for lymphoscintigraphy studies in preclinical models of peripheral snakebite envenomation0
Visualizing QT prolongation in the anesthetized guinea pig0
Test facility management: Responsibilities and paradigms of a new era0
Innovative approaches to cardiovascular safety pharmacology assessment0
MEA assessment to anti-epilepsy drugs in human iPSC-derived neural network0
Dosing in the dark—effect of time of dosing on preclinical safety profiles0
Effects of intracellular fluoride and temperature on hERG blocker potency in vitro0
AI analysis in MEA data of hiPSC-derived neurons is useful method for risk prediction of pesticides0
Editorial Board0
Chronic bladder catheterization for precise urine collection in awake mice0
Development of predictive inotropy in silico cardiac safety assay for drug candidate screening0
Editorial Board0
Three in silico human iPSC cardiomyocyte models to recapitulate in vitro drug trials0
Improved detection of compound arrhythmogenicity in 2D cardiac stem cell models via advanced maturation strategies0
Drug testing using a novel in silico human cardiac Purkinje cell model and comparison with experimental data0
Human iPS cell-derived cardiomyocytes aligning on flexible gelatin fiber network show contraction and pharmacological responses relevant to human heart0
Expanding the number of validated iPSC-derived cardiomyocytes for safety pharmacology studies0
Post-exercise hypotension induced by six-minutes walking test in dogs with naturally occurring mitral insufficiency0
A novel device for serial venous blood sampling in a canine model0
QA interval heart rate correction: Species comparison of an indirect ventricular contractility biomarker0
Mechanical stimulation in a 2D high-throughput contractility system induces functional changes in human induced pluripotent stem cell-derived cardiomyocytes0
Assessment of cardiac reserve and chronotropic effects using dobutamine stress echocardiography in healthy male rats0
Thirty years of telemetry-based data acquisition for cardiovascular drug safety evaluation: Applications and optimization0
Preclinical safety pharmacology risk assessment for oligonucleotides put into practice0
Optimization of an method for assessing pulmonary permeability of inhaled drugs using alveolar epithelial cells0
A case report of cardiovascular safety outcomes in mice supported by a pharmacodynamic biomarker0
Editorial Board0
Comparative analysis of high-throughput RNA extraction kits in Naïve Non-Human Primate (NHP) tissues for downstream applications utilizing Xeno Internal Positive Control (IPC)0
Evaluation of chronic drug-induced effects of oncologic compounds on cardiac function and cardiac biomarkers release in human induced pluripotent stem cell-derived cardiomyocytes0
Determination of unbound platinum concentrations in human plasma using ultrafiltration and precipitation methods0
Editorial Board0
Inhibition of hERG K channels by verapamil at physiological temperature: Implications for the CiPA initiative0
Corrigendum to “The in vivo QTc core assay: An evaluation of QTc variability, detection sensitivity and implications for the improvement of conscious dog and non-human primate telemetry studies” [Jour0
Biological variations in hemodynamics and electrocardiogram rhythms among telemetered cynomolgus monkeys0
Development and validation of an LC-MSMS method for the quantitation of pacritinib; application of kinetics in rabbits0
A bioanalytical assay for estimation of thymoquinone in rats cerebrospinal fluid and brain tissues of nasally administrated thymoquinone loaded lipo-polymeric nanoshells and its pharmacokinetic profil0
Identification of pharmacological targets involved in drug-induced thermoregulation impairment0
Determine the pharmacokinetics (half-life, volume of distribution and clearance) of AMB-FUBINACA in rats plasma using GC–MS / MS0
Editorial Board0
Modeling chemotherapy-induced peripheral neuropathy using a nerve-on-a-chip microphysiological system0
Neuroelectrophysiology assays performed on dorsal root ganglion from non-human primate and rodent origins0
Improved seizure liability detection by combining rat hippocampal brain slice electrophysiology with in vivo behavior observation following intracerebroventricular drug administration0
In vitro neurotoxicity testing using functional human iPSC-derived neurons0
Comparison of SYBR green I and lactate dehydrogenase antimalarial in vitro assay in Plasmodium falciparum field isolates0
Effect of hydroxychloroquine on proarrhythmia risk assessment using human iPSC-derived cardiomyocytes0
Combining human-based in silico and in vitro models of inherited cardiac diseases for drug safety and efficacy evaluation0
Editorial Board0
Improved screening of the cardiovascular safety of COVID-19 anti-viral compounds0
Artificial neural networks in cardiac safety assessment: Classification of chemotherapeutic compound effects on hiPSC-derived cardiomyocyte contractility0
Flavonoids from Chromolaena leivensis and Caesalpinia spinosa as potential protectors against doxorubicin-induced cardiomyopathy0
Identification of safety margins for polysorbate 80 exposure in canines0
Assessment of cardiac safety liabilities via 3D engineered heart tissue contractility using a novel high-throughput instrumentation platform0
A comparison of multiple left ventricular pressure endpoints as a screening tool in rats0
Blood microsampling in cynomolgus monkey and evaluation of plasma PK parameters in comparison to conventional sampling0
A cross-species comparison study of undesired drug-induced hypothermia using telemetry0
Circulating biomarkers of neurotoxicity: Proteomics approach reveals fluidic endpoints of central nervous system toxicity in a rodent model of neurotoxicity0
A novel nonhuman primate model of citric acid-induced cough0
Editorial Board0
Multiplexed structure-function assay for high throughput drug safety testing on human induced pluripotent stem cell-derived cardiomyocytes and neurons0
The efficient method to get better raw brain signal on rat anesthetics experiment0
CNS (EEG & behavior) safety assessment in freely moving/socially housed non-rodents0
Editorial Board0
Stress-free blood sampling in minipigs: A novel method for assessing 24-h cortisol profiles and drug effects on diurnal and ultradian rhythms0
Meeting abstracts, Eighteenth Annual Themed Issue on Methods in Safety Pharmacology0
Evaluation methods using tear volume in a conjunctivitis mice model0
First-order compartment model solutions – Exponential sums and beyond0
In-situ polyherbal gel as biomedicine in the management of Alzheimer's disease: Understanding ameliorative potential in Trimethyltin induced neurodegeneration0
Overcoming obstacles in three-dimensional cell culture model establishment: Approaches for growing A549 non-small cell lung cancer spheroids using a clinostat system0
Establishment of drug screening in human embryonic stem cells based on a high-content screening system0
Evaluating the proarrhythmic risk of delayed-action compounds in serum free cell culture conditions; serum-starvation accelerates/amplifies the effect of probucol on the KCNQ1 + KCNE1 channel0
A genetic algorithm-based approach for the prediction of metabolic drug-drug interactions involving CYP2C8 or CYP2B60
Preclinical comprehensive in vitro proarrhythmic assays demonstrate that omecamtiv mecarbil has low proarrhythmic risk0
Editorial Board0
Late sustained sodium current in the adult human heart0
The underlying molecular mechanisms of drug-induced seizures0
MEA assay with human iPSC-derived neurons generated by a rapid differentiation method0
The visual field-testing maze and vision maze: Feasible techniques to evaluate visual field loss in animals0
Model versus scientist: Cardiac toxicity predictions—safety pharmacologists correlate with the CiPA model0
Editorial Board0
Evaluation of four in silico biomarkers for drug-induced proarrhythmic risk: COVID-19 off-label therapies case study0
Comparison between collagen and fibrin matrices in 3D cardiac tissue engineering0
HS-GC-FID method for quantification of HFA-152a in cell culture media, and plasma from a range of species and regulatory compliant validations0
An integrative computational platform for the multiparametric analysis of cardiomyocyte signals0
Automated cardiac tissue assay system with perfusion for monitoring contractility0
Drug-target interaction prediction using reliable negative samples and effective feature selection methods0
Method of transverse aortic constriction in mice with reduced variability of the aortic peak pressure gradient0
Human engineered cardiac tissues grown in a plate-based platform for analysis of acute and chronic contractility response0
Effects of omecamtiv mecarbil on calcium-transients and contractility in a translational canine myocyte model0
Assessment of sarcomere shortening and calcium transient in primary human and dog ventricular myocytes0
Translational understanding of PDE4 inhibition0
0.087841033935547